1α,25-(OH) vitamin D prevents insulin resistance and regulates coordinated exocytosis and insulin secretion.

Vitamin D is associated with improvements in insulin resistance and glycemia. In this study, we investigated the short-term effect of 1α,25(OH) Vitamin D (1,25-D) and cholecalciferol (vitamin D) on the glycemia and insulin sensitivity of control and dexamethasone-induced insulin-resistance rats. Ca influx responses to 1,25-D and its role in insulin secretion were investigated in isolated pancreatic islets from control rats. In vivo, 5 d treatment with 1,25-D (i.p.) prevented insulin resistance in dexamethasone-treated rats. Treatment with 1,25-D improved the activities of hepatic enzymes, serum lipids and calcium concentrations in insulin-resistant rats. 25-D (o.g.) does not affect insulin resistance. In pancreatic islets, 1,25-D increased insulin secretion and stimulated rapid response Ca influx. The stimulatory effect of 1,25-D on Ca influx was decreased by diazoxide, apamine, thapsigargin, dantrolene, 2-APB, nifedipine, TEA, PKA, PKC, and cytoskeleton inhibitor, while it was increased by glibenclamide and N-ethylmaleimide. The stimulatory effect of 1,25-D on Ca influx involves the activation of L-type VDCC, K-ATP, K-Ca and Kv channels, which augment cytosolic calcium. These ionic changes mobilize calcium from stores and downstream activation of PKC, PKA tethering vesicle traffic and fusion at the plasma membrane for insulin secretion. This is the first study highlighting the unprecedented role of 1,25-D (short-term effect) in the regulation of glucose homeostasis and on prevention of insulin resistance. Furthermore, this study shows the intracellular β-cell signal transduction of 1,25-D through the modulation of pivotal ionic channels and proteins exhibiting a coordinated exocytosis of vesicles for insulin secretion.